BABY News Alert Natus Medical Inc (BABY) 36.96 02/14/2015 20

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Natus Medical Inc (BABY) 36.96 $BABY

Natus Medical Earnings: The Stock Has Some Upside Left
Andy Batts - at Seeking Alpha - Thu Feb 12, 9:43AM CST

BABY: 36.96 (-0.03)

Natus Medical Up 42.4% Since SmarTrend Uptrend Call (BABY)
Comtex SmarTrend(R) - Wed Feb 11, 9:19AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 10 months, Natus Medical has returned 42.39% as of today's recent price of $37.15.
BABY: 36.96 (-0.03)

Uptrend Call Working As Natus Medical Stock Rises 41.4% (BABY)
Comtex SmarTrend(R) - Tue Feb 03, 5:06PM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 10 months, Natus Medical has returned 41.36% as of today's recent price of $36.88.
BABY: 36.96 (-0.03)

Natus Medical (BABY) Beats Q4 Earnings, Revenues in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 2:20PM CST
Provider of newborn care and neurology healthcare products, Natus Medical Inc. (BABY), reported adjusted earnings per share (EPS) of 40 cents in the fourth quarter of 2014
BABY: 36.96 (-0.03), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), EW: 134.23 (+1.89)

Natus Medical Has The Right Growth Metrics BABY
Chris Katje - at Seeking Alpha - Thu Jan 29, 11:10AM CST

BABY: 36.96 (-0.03)

Natus Medical's (BABY) CEO James Hawkins on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Jan 28, 4:24PM CST

BABY: 36.96 (-0.03)

Natus Medical Inc. Serves Up a New Business Model
Brian Orelli, The Motley Fool - Motley Fool - Wed Jan 28, 2:26PM CST
Natus Medical continues to fire on all cylinders. It's hard to find something to complain about the medical device maker specializing in neurology and care for newborns. Even the numbers that don't look good have positive causes. Take, for...
BABY: 36.96 (-0.03)

Natus Medical Incorporated (BABY) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Jan 28, 9:55AM CST

BABY: 36.96 (-0.03)

Natus Medical raises guidance after Q4 results
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:09AM CST

BABY: 36.96 (-0.03)

Natus Medical beats 4Q profit forecasts
Automated Insights - Wed Jan 28, 7:52AM CST
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported fourth-quarter earnings of $9.9 million.
BABY: 36.96 (-0.03)

Natus Medical beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 6:03AM CST

BABY: 36.96 (-0.03)

Natus Medical Announces Record Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Wed Jan 28, 6:00AM CST
- Increases 2015 revenue and earnings guidance
BABY: 36.96 (-0.03)

Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 4:30PM CST

ARLP: 39.29 (+1.84), CRS: 42.01 (+0.81), MKC: 74.64 (+0.33), PCH: 39.96 (-0.04), RYAM: 17.58 (+0.36), EAT: 59.16 (-0.18), ENR: 138.49 (+3.42), AEP: 57.83 (-0.15), PGR: 27.11 (+0.06), BABY: 36.96 (-0.03), CFR: 69.19 (+1.16), ROL: 33.74 (-0.01), ROK: 117.90 (+1.02), RES: 13.36 (+0.93), HES: 76.83 (+2.12), TROW: 82.45 (+0.17), IP: 57.31 (+0.12), GNTX: 17.81 (+0.27), TXT: 44.68 (+0.49), BA: 149.73 (+1.64), HCBK: 9.92 (+0.03), GIB: 41.90 (+0.05), ADT: 38.21 (+0.11), TUP: 72.53 (+0.44), KLIC: 16.00 (-0.30), AME: 51.41 (+0.80), KNX: 32.26 (+0.88), STJ: 67.48 (+0.65), PX: 126.89 (+1.53), STM: 8.91 (-0.21), MDP: 54.72 (+0.19), GD: 137.61 (-0.54), ABMD: 60.39 (+0.46), MKTX: 81.22 (-0.66), ACAT: 39.00 (+1.31), SEIC: 43.20 (+0.07), BOKF: 59.26 (+0.19), CVLT: 43.68 (-0.05), ANTM: 141.05 (-0.95), HTCH: 3.71 (+0.09), MDC: 27.38 (-0.24), AHGP: 53.10 (+1.92), TEL: 70.76 (+0.38), RDWR: 20.85 (+0.42), BAH: 30.16 (+0.18), FCAU: 14.53 (+0.06), SPIL: 8.69 (+0.14), EVER: 18.26 (-0.01), ABC: 100.34 (+0.51), MTOR: 14.33 (+0.38)

Shares of BABY Up 41.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 27, 11:12AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 9 months, Natus Medical has returned 41.20% as of today's recent price of $36.84.
BABY: 36.96 (-0.03)

Natus Medical buys Global Neuro-Diagnostics to enter the neurodiagnostic services market
M2 - Tue Jan 27, 4:22AM CST
Healthcare company Natus Medical (NasdaqGS:BABY) revealed on Monday that it has completed its acquisition of Global Neuro-Diagnostics (GND), marking its entry into the neurodiagnostic services market.
BABY: 36.96 (-0.03)

Natus Medical Announces Entry Into Neurodiagnostic Services Market
GlobeNewswire - Mon Jan 26, 6:00AM CST
? Acquires Global Neuro-Diagnostics ("GND" , a Pioneer in Neurodiagnostic Services
BABY: 36.96 (-0.03)

Echo Therapeutics Restores Pact with MTIA, Issues Patent - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 4:05PM CST
Echo Therapeutics Inc. (ECTE), a firm engaged in the development of transdermal skin permeation and diagnostic medical devices, recently announced re-establishment of its contract with Medical Technologies Innovation Asia (MTIA), Ltd.
ECTE: 2.62 (+0.06), BABY: 36.96 (-0.03), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)

Natus Medical's a Strong Buy on Expanding Product Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 12:00PM CST
On Jan 22, 2015, Zacks Investment Research raised Natus Medical Inc. (BABY) to a Zacks Rank #1 (Strong Buy).
XENT: 23.06 (+0.46), BABY: 36.96 (-0.03), JNJ: 99.62 (+1.18), INGN: 33.53 (+2.32)

Is Natus Medical (BABY) a Great Growth Stock? - Tale of the Tape
Abhijit Ghosh - Zacks Investment Research - Wed Jan 21, 7:32AM CST
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention and produce gains; and one such company that might be well-positioned for future earnings growth is Natus Medical.
BABY: 36.96 (-0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Montessori and Tech: A New Era of Integration

Updated Category News Views 13

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 15

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Fluence Energy Faces Major Lawsuit Amid $3B Loss

Updated Category News Views 7

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 12

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 15

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 22

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 17

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 10

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 14

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 12

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading

Top 5 Most Recently Viewed Articles

Rohirrim Introduces RohanProcure for Advanced Gov Procurement

Updated Category News Views 604

Rohirrim Unveils RohanProcure to Transform Government Procurement Rohirrim, an innovative leader in AI technologies, has recently launched RohanProcure, a specialized platform aimed at modernizing government procurement processes. This cutting-edge, single-tenant, defense-grade GenAI solution is designed to streamline acquisition workflows, significantly reducing clerical...

Continue Reading
Elite Supplements Partners with Coveo for Enhanced Ecommerce Growth

Updated Category News Views 76

Elite Supplements and Coveo: A Strategic Collaboration In a bold move towards enhancing customer experience, Australian sports-nutrition innovator Elite Supplements has teamed up with Coveo and Shopify. This strategic partnership aims to elevate product discovery, personalization, and conversion across their extensive 130-store omnichannel brand. Elite Supplements, one of...

Continue Reading
ALK's ITULAZAX® Approval Marks Progress in Allergy Treatment

Updated Category News Views 188

ALK's Innovative ITULAZAX® Tablet Gains NICE Recommendation ALK (ALKB:DC / OMX: ALK B) is thrilled to announce a significant advancement in allergy treatment with the National Institute for Health and Care Excellence (NICE) recommending the company’s tree pollen tablet, ITULAZAX®, for adult patients. This critical endorsement enables easier access through the National...

Continue Reading
AMG Critical Materials Sells Graphit Kropfmühl to Asbury Carbons

Updated Category News Views 315

AMG Critical Materials Finalizes Sale of Graphit Kropfmühl GmbH AMG Critical Materials N.V. (EURONEXT AMSTERDAM: AMG) recently confirmed a significant business move with its decision to sell Graphit Kropfmühl GmbH (GK) to Asbury Carbons Inc. This strategic transaction aligns with AMG's intention to prioritize its core operations and harness new growth opportunities....

Continue Reading
Impact Climate Technologies Expands with New Acquisition

Updated Category News Views 131

Impact Climate Technologies Strengthens Its Portfolio Impact Climate Technologies (ICT), a prominent player in the HVAC industry, has announced its latest strategic move to enhance its capabilities by acquiring Larry Wunsch & Associates, Inc. This acquisition is set to bolster ICT's operational footprint while expanding its service offerings in the HVAC and plumbing...

Continue Reading